|    Join     |    Donate    |   Store    |   About NAMS
Facebook TwitterYouTubeLinkedinRSS

Practice Pearls Details

Practice Pearls is a series of clinical overviews and perspectives that tackle challenging problems in the care of women at midlife and beyond. These were launched in 2012 in response to NAMS members’ requests for guidelines on specific topics that they could reference and share with colleagues. The NAMS Board of Trustees reviews and approves the topics and authors for all Practice Pearls.

Practice Pearls are a members-only benefit and NAMS members may earn continuing medical education (CME) credits or certificates of participation for reading Practice Pearls and completing an evaluation. Each Practice Pearl offers CME credit and, depending on content, pharmacotherapeutics hours. Practice Pearls CME credits are available for 1 year after the release date.

These are the list of Practice Pearls that were published during 2019-2022. To access Practice Pearls, join NAMS today.


2024 Practice Pearls With CME

—Postmenopausal Dyspareunia (CME availalble until July 17, 2025)

—Neurokinin Receptor Antagonists as Potential Nonhormone Treatments for Vasomotor Symptoms (CME available until May 23, 2025)

—Menopause and Brain Fog: How to Counsel and Treat Midlife Women (CME available until March 21, 2025)

—Sexually Transmitted Infections in Midlife Women (CME available until January 9, 2025)

2023 Practice Pearls With CME

—Fractional CO2 Laser for Genitourinary Syndrome of Menopause: Evaluating the Evidence (CME available until November 28, 2024)

—Primary Ovarian Insufficiency: A Toolkit for the Busy Clinician (CME available until September 6, 2024)


—Reproductive Risk Factors for Cardiovascular Disease in Women (CME available until August 10, 2024)

—Evaluation and Treatment of Vulvovaginal Itching in Postmenopausal Women 

—Testosterone Use for Hypoactive Sexual Desire Disorder in Postmenopausal Women

—The Menopause Transition: A Critical Stage for Cardiovascular Disease Risk Acceleration in Women

2022 Practice Pearls

—Clinical Considerations for Menopause and Associated Symptoms in Women With HIV

—Aspirin for Primary Prevention of Cardiovascular Disease in Women

—Should Vitamin D Supplements Be Prescribed Routinely for Midlife Women? 

—Clinical Management of Hypoactive Sexual Desire Disorder in Postmenopausal Women

—Lifestyle and Breast Cancer Risk Reduction 

—Update on Migraine Management

2021 Practice Pearls

—Practice Considerations for Behavioral Therapies for Depression and Anxiety in Midlife Women 

—Select Immunizations for Adult Women 

—Addressing Intimate Partner Violence With Midlife Women: Awareness, Support, Empowerment 

—Statin Therapy in Midlife Women 

—Cognitive-Behavior Therapy for Sleep Disorders at Midlife 

2020 Practice Pearls 

—Compounded Bioidentical Hormone Therapy: New Recommendations From the 2020 National Academies of Sciences, Engineering, and Medicine

—Genitourinary Syndrome of Menopause: The Unmet Need 

—What Providers Need to Know About Progestogens in Hormone Therapy 

—Fibromyalgia Screening in Patients With Unexplained Chronic Fatigue 

—The Safety of Oral Versus Transdermal Estrogen 

—Aspirin for Primary Prevention of Cardiovascular Disease in Women 

2019 Practice Pearls

—Taking a Fresh Look at Mood, Hormones, and Menopause 

—Supplemental Screening in the Dense Breast: Does Molecular Breast Imaging Have a Role? 

—Identification and Management of Urinary Incontinence in Midlife Women 

—Salpingectomy to Reduce Risk of Ovarian Cancer in Women at Average Risk 

—Clinical Care of Women With Intermediate Breast Cancer Risk 

—Adnexal Tumors in Menopausal Women: Surgery or Surveillance?



ACCME

Copyright© 2024 |  Home  |  Privacy Policy  |   Site Map |

 

30050 Chagrin Blvd, Suite 120W - Pepper Pike, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 2 + 0.